BioCentury
ARTICLE | Clinical News

AR-12 regulatory update

May 11, 2015 7:00 AM UTC

The European Commission granted Orphan Drug designation to AR-12 from Arno to treat cryptococcosis and tularemia. The small molecule 3-phosphoinositide dependent protein kinase-1 (PDPK1) inhibitor is...